Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Emergent Biosolutions Inc’s current trading price is -62.58% away from its 52-week high, while its distance from the 52-week low is 40.55%. The stock’s price range over this period has fluctuated between $4.02 and $15.10. The company, operating within the financial sector, had a trading volume of approximately 1.97 million for the day, which was noticeably higher than the average daily share volume of 1.3 million over the last 3 months.
Emergent Biosolutions Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $15.10 on 07/30/24 and the lowest value was $4.02 on 04/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Emergent Biosolutions Inc (EBS) has experienced a quarterly decline of -43.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 307.02M and boasts a workforce of 900 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.37, with a change in price of -3.04. Similarly, Emergent Biosolutions Inc recorded 1,211,486 in trading volume during the last 100 days, posting a change of -34.98%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for EBS stands at 1.22. Similarly, the long-term debt-to-equity ratio is also 1.21.
EBS Stock Stochastic Average
Today, Emergent Biosolutions Inc’s raw stochastic average for the past 50 days stands at 45.46%, indicating a decline from the raw stochastic average of the last 20 days, which was 59.14%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 62.92% and 56.48% respectively.
EBS Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -40.90% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -36.94%. Over the past 30 days, the price of EBS has fallen by 20.47%. And in the last five days, it has surged by 9.92%.
